vs

Side-by-side financial comparison of Akamai Technologies (AKAM) and DENTSPLY SIRONA Inc. (XRAY). Click either name above to swap in a different company.

Akamai Technologies is the larger business by last-quarter revenue ($1.1B vs $961.0M, roughly 1.1× DENTSPLY SIRONA Inc.). Akamai Technologies runs the higher net margin — 9.9% vs -15.2%, a 25.1% gap on every dollar of revenue. On growth, DENTSPLY SIRONA Inc. posted the faster year-over-year revenue change (6.2% vs -2.3%). Over the past eight quarters, Akamai Technologies's revenue compounded faster (4.7% CAGR vs 0.4%).

Akamai Technologies, Inc. provides cloud services for securing, delivering, and optimizing content and business applications over the internet in the United States and internationally. The company offers cloud solutions to keep infrastructure, websites, applications, application programming interfaces, and users safe from various cyberattacks and online threats while enhancing performance. It also provides web and mobile performance solutions to enable dynamic websites and applications; media...

Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million.

AKAM vs XRAY — Head-to-Head

Bigger by revenue
AKAM
AKAM
1.1× larger
AKAM
$1.1B
$961.0M
XRAY
Growing faster (revenue YoY)
XRAY
XRAY
+8.5% gap
XRAY
6.2%
-2.3%
AKAM
Higher net margin
AKAM
AKAM
25.1% more per $
AKAM
9.9%
-15.2%
XRAY
Faster 2-yr revenue CAGR
AKAM
AKAM
Annualised
AKAM
4.7%
0.4%
XRAY

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AKAM
AKAM
XRAY
XRAY
Revenue
$1.1B
$961.0M
Net Profit
$106.3M
$-146.0M
Gross Margin
98.0%
46.1%
Operating Margin
10.7%
-14.5%
Net Margin
9.9%
-15.2%
Revenue YoY
-2.3%
6.2%
Net Profit YoY
-13.7%
66.0%
EPS (diluted)
$0.71
$-0.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AKAM
AKAM
XRAY
XRAY
Q1 26
$1.1B
Q4 25
$1.1B
$961.0M
Q3 25
$1.1B
$904.0M
Q2 25
$1.0B
$936.0M
Q1 25
$1.0B
$879.0M
Q4 24
$1.0B
$905.0M
Q3 24
$1.0B
$951.0M
Q2 24
$979.6M
$984.0M
Net Profit
AKAM
AKAM
XRAY
XRAY
Q1 26
$106.3M
Q4 25
$85.1M
$-146.0M
Q3 25
$140.2M
$-427.0M
Q2 25
$103.6M
$-45.0M
Q1 25
$123.2M
$20.0M
Q4 24
$139.9M
$-430.0M
Q3 24
$57.9M
$-494.0M
Q2 24
$131.7M
$-4.0M
Gross Margin
AKAM
AKAM
XRAY
XRAY
Q1 26
98.0%
Q4 25
58.7%
46.1%
Q3 25
59.3%
48.8%
Q2 25
59.1%
52.4%
Q1 25
58.7%
53.0%
Q4 24
59.4%
49.3%
Q3 24
59.3%
52.1%
Q2 24
58.9%
51.9%
Operating Margin
AKAM
AKAM
XRAY
XRAY
Q1 26
10.7%
Q4 25
8.7%
-14.5%
Q3 25
15.7%
-24.1%
Q2 25
14.5%
-13.7%
Q1 25
15.2%
7.2%
Q4 24
14.5%
-56.2%
Q3 24
7.0%
-48.6%
Q2 24
15.1%
5.1%
Net Margin
AKAM
AKAM
XRAY
XRAY
Q1 26
9.9%
Q4 25
7.8%
-15.2%
Q3 25
13.3%
-47.2%
Q2 25
9.9%
-4.8%
Q1 25
12.1%
2.3%
Q4 24
13.7%
-47.5%
Q3 24
5.8%
-51.9%
Q2 24
13.4%
-0.4%
EPS (diluted)
AKAM
AKAM
XRAY
XRAY
Q1 26
$0.71
Q4 25
$0.57
$-0.74
Q3 25
$0.97
$-2.14
Q2 25
$0.71
$-0.22
Q1 25
$0.82
$0.10
Q4 24
$0.92
$-2.09
Q3 24
$0.38
$-2.46
Q2 24
$0.86
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AKAM
AKAM
XRAY
XRAY
Cash + ST InvestmentsLiquidity on hand
$622.4M
$326.0M
Total DebtLower is stronger
$2.3B
Stockholders' EquityBook value
$4.9B
$1.3B
Total Assets
$11.6B
$5.4B
Debt / EquityLower = less leverage
1.70×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AKAM
AKAM
XRAY
XRAY
Q1 26
$622.4M
Q4 25
$1.2B
$326.0M
Q3 25
$1.1B
$363.0M
Q2 25
$966.6M
$359.0M
Q1 25
$1.3B
$398.0M
Q4 24
$1.6B
$272.0M
Q3 24
$1.7B
$296.0M
Q2 24
$1.6B
$279.0M
Total Debt
AKAM
AKAM
XRAY
XRAY
Q1 26
Q4 25
$2.3B
Q3 25
Q2 25
Q1 25
Q4 24
$1.7B
Q3 24
Q2 24
Stockholders' Equity
AKAM
AKAM
XRAY
XRAY
Q1 26
$4.9B
Q4 25
$5.0B
$1.3B
Q3 25
$4.7B
$1.5B
Q2 25
$4.5B
$2.0B
Q1 25
$4.6B
$2.0B
Q4 24
$4.9B
$1.9B
Q3 24
$4.8B
$2.5B
Q2 24
$4.8B
$3.1B
Total Assets
AKAM
AKAM
XRAY
XRAY
Q1 26
$11.6B
Q4 25
$11.5B
$5.4B
Q3 25
$10.8B
$5.7B
Q2 25
$10.5B
$6.1B
Q1 25
$10.0B
$6.0B
Q4 24
$10.4B
$5.8B
Q3 24
$10.2B
$6.6B
Q2 24
$10.1B
$6.9B
Debt / Equity
AKAM
AKAM
XRAY
XRAY
Q1 26
Q4 25
1.70×
Q3 25
Q2 25
Q1 25
Q4 24
0.90×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AKAM
AKAM
XRAY
XRAY
Operating Cash FlowLast quarter
$312.5M
$101.0M
Free Cash FlowOCF − Capex
$60.0M
FCF MarginFCF / Revenue
6.2%
Capex IntensityCapex / Revenue
19.2%
4.3%
Cash ConversionOCF / Net Profit
2.94×
TTM Free Cash FlowTrailing 4 quarters
$104.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AKAM
AKAM
XRAY
XRAY
Q1 26
$312.5M
Q4 25
$366.6M
$101.0M
Q3 25
$441.8M
$79.0M
Q2 25
$459.1M
$48.0M
Q1 25
$251.2M
$7.0M
Q4 24
$343.8M
$87.0M
Q3 24
$392.5M
$141.0M
Q2 24
$431.0M
$208.0M
Free Cash Flow
AKAM
AKAM
XRAY
XRAY
Q1 26
Q4 25
$234.9M
$60.0M
Q3 25
$329.1M
$40.0M
Q2 25
$313.6M
$16.0M
Q1 25
$133.4M
$-12.0M
Q4 24
$250.9M
$36.0M
Q3 24
$279.7M
$98.0M
Q2 24
$340.0M
$156.0M
FCF Margin
AKAM
AKAM
XRAY
XRAY
Q1 26
Q4 25
21.5%
6.2%
Q3 25
31.2%
4.4%
Q2 25
30.1%
1.7%
Q1 25
13.1%
-1.4%
Q4 24
24.6%
4.0%
Q3 24
27.8%
10.3%
Q2 24
34.7%
15.9%
Capex Intensity
AKAM
AKAM
XRAY
XRAY
Q1 26
19.2%
Q4 25
12.0%
4.3%
Q3 25
10.7%
4.3%
Q2 25
13.9%
3.4%
Q1 25
11.6%
2.2%
Q4 24
9.1%
5.6%
Q3 24
11.2%
4.5%
Q2 24
9.3%
5.3%
Cash Conversion
AKAM
AKAM
XRAY
XRAY
Q1 26
2.94×
Q4 25
4.31×
Q3 25
3.15×
Q2 25
4.43×
Q1 25
2.04×
0.35×
Q4 24
2.46×
Q3 24
6.78×
Q2 24
3.27×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AKAM
AKAM

Security$589.8M55%
Delivery and other cloud applications$389.2M36%
Cloud Infrastructure Services$94.6M9%

XRAY
XRAY

Essential Dental Solutions$372.0M39%
Equipment And Instruments$160.0M17%
Implants And Prosthetics$150.0M16%
CADCAM$139.0M14%
Wellspect Healthcare$88.0M9%
Orthodontics$52.0M5%

Related Comparisons